PIKUACH NEFESH ALERT: What To Do If You Test Positive and Are High Risk


    By Rabbi Yair Hoffman for 5tjt.com

    Click to get Text Message Updates right to your phone

    Join our WhatsApp group

    This article is one of PIKUACH NEFESH.  Please take it very seriously and forward the content to anyone who is COVID positive and has a risk factor.

    As many people know, I had recently been hospitalized with COVID.   There are ways to seriously minimize the effects of COVID – which many people are unaware of.  When I was in the height of it, I tried to get Monoclonal Antibodies – but it was not available. An organization got me into Mt. Sinai, and  I was given plasma antibodies, and that, in combination with steroids, antiviral Resvedevir and anticoagulants helped me significantly.

    Monoclonal Antibodies, however, are even better than plasma antibodies – reducing hospitalization rates up to 70% according to the latest studies.   

    People who test positive must let their physician know early on, and not allow themselves to be treated at home with oxygen etc. without physician supervision. Once someone is on O2, they will not qualify for monoclonal anymore.  There are protocols in numerous hospitals that allow physician to get their patients treated as outpatients.

    There is an organization called CPI (call 828 4 PLASMA) which can help patients get into to the following six places that offer this treatment. [There are more of course]. This organization got me into treatment at Mt. Sinai.  Their email is: [email protected] and the website is – PlasmaHeroes.com

    1. Sinai (NYC)
    2. Maimonides (Brooklyn)
    3. Northwell (SI and LI)
    4. Good Samaritan (Rockland)
    5. Monmouth Medical Center South Campus (Lakewood, NJ)
    6. Hackensack Meridian Health (NJ)

    Not enough people know about it.   Tell anyone you know.  It was originally approved by the FDA in November.  The first one was made by Eli Lilly and called, “Bamlanivimab.”   received an emergency use authorization from the US Food and Drug Administration in early November. Less than two weeks later, the agency granted an EUA to Regeneron’s monoclonal antibody cocktail, made up of two monoclonal antibodies, Casirivimab and Imdevimab, and called REGEN-COV2.

    This second one was the one given to President Trump.  It worked fabulously.

    The fact is that according to the FDA, monoclonal antibodies should be given as soon as possible after symptoms emerge.

    So as soon as you test positive call that number.  They will prioritize high risk people who are a] 65 or older, or b] BMI of 35 or more or c] underlying health conditions.


    The author can be reached at [email protected]

    Listen to the VINnews podcast on:

    iTunes | Spotify | Google Podcasts | Stitcher | Podbean | Amazon

    Follow VosIzNeias For Breaking News Updates

    Most Voted
    Newest Oldest
    Inline Feedbacks
    View all comments